Hyperbaric Oxygen Therapy for Long COVID: What the Research Actually Supports

If you have long COVID, you have probably encountered two versions of hyperbaric oxygen therapy.

The first says it's a breakthrough — proof that your symptoms were real all along and that a chamber is the answer. The second says it's expensive wellness theater with nothing behind it.

Neither version is honest. And neither one is coming from someone who has read the papers.

The real picture is more useful than either. There is now a randomized, sham-controlled trial of hyperbaric oxygen for post-COVID condition. There is a one-year follow-up on those patients. And there is a 232-patient registry from six European hyperbaric centers. That is meaningfully better than anecdote. It is also meaningfully worse than settled science.

Both things are true at the same time, and this article is about living in that space honestly.

Why oxygen under pressure would matter at all

Inside a hyperbaric chamber, the air pressure around you increases. Under that pressure, oxygen dissolves directly into your blood plasma — the fluid part of your blood — rather than riding only on red blood cells.

That matters because plasma goes places crowded red blood cells struggle to reach. Small vessels. Poorly supplied tissue. Regions of the brain running on a reduced supply.

Researchers are interested in this for long COVID specifically because a growing body of work suggests much of long COVID behaves like a blood vessel and blood flow problem rather than a lung problem. The brain imaging in the 2022 trial is consistent with that idea: the treated group showed increased perfusion in brain regions associated with cognitive and emotional function.

That makes the mechanism plausible. Plausible is not the same as proven, and the distinction matters for everything that follows.

The three pieces of evidence, in order of strength

1. The randomized controlled trial (2022)

Seventy-three patients with post-COVID condition were randomized to either hyperbaric oxygen or a sham protocol. Neither the patients nor the evaluators knew who received the real treatment. The protocol was 40 sessions at 2.0 ATA over two months.

The treated group showed statistically significant improvements with medium effect sizes in global cognitive function, attention, and executive function, along with improvements in energy, sleep quality, psychiatric symptoms, and pain interference.

Those are real, measured results from a properly controlled design. They are also from a single trial of 73 people, with a short follow-up window — limitations the authors themselves named.

2. The one-year follow-up (2024)

Thirty-one of those patients were re-evaluated roughly 486 days after their final session. The improvements in sleep, neuropsychiatric symptoms, pain, and quality of life were still present, with no statistically significant regression.

Durability matters. A great many interventions produce a bump that vanishes the moment you stop. This one appears not to.

The caveat: 31 patients, and the original sham group was no longer available as a comparison, because most of them had since received treatment themselves.

3. The prospective registry (2025)

Six Dutch hyperbaric centers tracked 232 long COVID patients treated between 2023 and 2024. This was not a mild cohort — the median patient had been ill for 20 months before starting. Protocol was 40 sessions at 2.4–2.5 ATA.

At three months, 56–63% showed a clinically relevant improvement in mental or physical quality-of-life scores. Symptom-level improvement was reported for word-finding problems in 73% of cases, memory problems in 70%, and brain fog in 68%.

Those numbers are striking. And the registry had no control group, which means causation cannot be established. Patients also self-funded an off-label treatment, which introduces selection bias. The authors are explicit that randomized controlled trials are still needed.

The finding almost nobody quotes

In that same registry, 13–19% of patients experienced a clinically relevant deterioration.

And fatigue produced the messiest result of the entire dataset: among patients whose fatigue was mild at baseline, 43% reported it got worse.

That number deserves your full attention, because there is a reason it happens.

Post-exertional malaise, and why "more" backfires

Here is something we see in the clinic every week, in a much milder form.

Someone decides to get back in shape. They train hard, five days a week, straight out of the gate. Exercise is good for you — everybody knows that. Four weeks later they are exhausted, sore, sleeping badly, and quitting.

The exercise was never the problem. The dose was.

Training does not make you stronger. Recovering from training makes you stronger. Without adequate recovery, the same workout that builds one person breaks another.

Now turn that principle up several orders of magnitude. In a study of 465 long COVID patients, 58% met criteria for ME/CFS — myalgic encephalomyelitis / chronic fatigue syndrome. The defining feature of that condition is not tiredness. It is that exertion makes you sick: effort that would be trivial for a healthy person triggers a system-wide crash a day or two later. Clinicians call this post-exertional malaise.

For that population, aggressive anything backfires. Aggressive exercise. Aggressive schedules. Aggressive treatment protocols.

And a hyperbaric protocol is not exempt from that math. Forty sessions in eight weeks is a genuine physiological load. Traveling to a clinic five days a week is a load all by itself, before the chamber door even closes.

Good input, wrong dose, worse outcome.

The Tolerance Dose

So the question is never simply "does this work."

The question is: what dose can your system actually absorb right now?

We call this the Tolerance Dose. You are not looking for the strongest available protocol. You are looking for the strongest protocol your body can absorb without crashing. Those are two completely different targets, and confusing them is how well-intentioned treatment makes people worse.

Choosing between 1.3, 1.5, and 2.0 ATA

At HealthFit in Pasadena we run three chamber levels: 1.3, 1.5, and 2.0 atmospheres absolute.

Here is the part the industry does not like to say plainly: the long COVID research was conducted at 2.0 ATA and above. If your goal is to match what the studies actually tested, that is the number that corresponds.

But matching the study is not the same as matching the patient.

For someone who crashes after a trip to the grocery store, starting at 2.0 is often the wrong move. Milder pressure is gentler, better tolerated, and far easier to stay consistent with — and consistency is what produces results in every recovery protocol we have ever run. You can bring your phone in. You can read. You can simply breathe and be still.

More pressure is not automatically better. More pressure is more stimulus, and stimulus only helps when your system can recover from it. That is not a hyperbaric rule. That is a biology rule.

The right starting point depends on how reactive your system is today, not on which number sounds most impressive in a brochure.

Where hyperbaric oxygen actually fits

Hyperbaric oxygen is one layer. It is not the plan.

The plan includes sleep you actively protect. Carefully paced activity that respects your crash threshold. Metabolic testing, so we stop guessing about your capacity and start measuring it. And your physician, positioned at the center of your care rather than off to the side.

Nothing in this article replaces that relationship. Bring these studies to your doctor. Ask hard questions. Make anyone offering you a treatment earn your trust with data rather than enthusiasm.

That is what a real plan looks like — layers that support each other, matched to where your body actually is.

And it starts with something that has nothing to do with a chamber. It starts with being believed.

HealthFit Physical Therapy & Chiropractic
145 Vista Ave, Suite 103, Pasadena, CA 91107 · 626-365-1380
Serving Pasadena, South Pasadena, Altadena, Sierra Madre, Arcadia, San Marino, Monrovia, Alhambra, San Gabriel, and La Cañada Flintridge.
Book a consultation · www.healthfitinc.com

This article is for general education and is not medical advice. It does not diagnose or treat any condition and is not a substitute for care from your physician. Hyperbaric oxygen therapy for long COVID is not an FDA-approved indication. Always consult your physician before beginning any new treatment.